A Day Up For Evofem Biosciences, Inc.
Tue, Dec 12, 2023 at 07:15 PM
Evofem Biosciences, Inc. (EVFM:NASDAQ) rocketted at $0.1, a gain of 35.7%. On Tue, Dec 12, 2023, EVFM:NASDAQ touched a New 2-Week High of $0.1. The stock appeared on our News Catalysts scanner on Tue, Dec 12, 2023 at 10:23 AM in the 'AGREEMENT' category. From Tue, Nov 28, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Dec 12, 2023 at $0.23 with a volume of 8M+.
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 150%
- C4 Therapeutics Inc. (CCCC:NASDAQ), 98.31%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- Kubient Inc. (KBNT:NASDAQ), 62.5%
- Aditxt Inc. (ADTX:NASDAQ), 60.26%
- Icosavax Inc. (ICVX:NASDAQ), 49.48%
- Chanson International Holding (CHSN:NASDAQ), 36.56%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 35.71%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 35.05%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 34%